Merck KGaA launches new digital ‘lifeline’ to help patients finance fertility treatmentnews2021-12-07T21:16:29+00:00December 7th, 2021|Fierce Pharma|
Call for nominations: The Most Influential People in Biopharmanews2021-12-07T19:22:41+00:00December 7th, 2021|Fierce Pharma|
Former pharma CEO plundered millions from his own company, DOJ saysnews2021-12-07T16:16:35+00:00December 7th, 2021|Fierce Pharma|
Watch out, Pfizer and Alnylam. AstraZeneca wades deeper into rare diseases with Ionis tie-upnews2021-12-07T15:42:18+00:00December 7th, 2021|Fierce Pharma|
GlaxoSmithKline and Vir’s sotrovimab stands up to omicron despite other COVID antibodies falling shortnews2021-12-07T15:40:19+00:00December 7th, 2021|Fierce Pharma|
Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trialnews2021-12-07T14:58:44+00:00December 7th, 2021|Fierce Pharma|
Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trialnews2021-12-07T14:58:44+00:00December 7th, 2021|Fierce Pharma|
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debutnews2021-12-07T14:37:35+00:00December 7th, 2021|Fierce Pharma|
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debutnews2021-12-07T14:37:35+00:00December 7th, 2021|Fierce Pharma|
PureTech’s oral drug delivery work spawns clinical-phase challenger to Sage in depressionnews2021-12-07T14:28:25+00:00December 7th, 2021|Fierce Pharma|
